Clincosm LogoSign in Get a demo

Metastatic Hepatocellular Carcinoma

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Not yet recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +10 more
  • Ipilimumab
  • Nivolumab
  • Miami, Florida
  • +4 more
Aug 23, 2022

Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +

Recruiting
  • Metastatic Esophageal
  • +7 more
  • LVGN3616 + LVGN6051 + Nab-Paclitaxel
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +33 more
  • Communication Intervention
  • +2 more
  • New York, New York
  • +3 more
Jun 29, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco

Recruiting
  • Stage IV Esophageal Adenocarcinoma
  • +43 more
  • Radiation Therapy (RT)
  • San Francisco, California
    University of California, San Francisco
Mar 29, 2022

Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma

Not yet recruiting
  • Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +45 more
  • Internet-Based Intervention
  • +2 more
  • Manhasset, New York
  • +3 more
Mar 30, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

Active, not recruiting
  • Metastatic Hepatocellular Carcinoma
  • +7 more
  • IDO1 Inhibitor BMS-986205
  • Nivolumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial in China (Lenvatinib,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Hefei, Anhui, China
  • +9 more
Oct 21, 2021

Metastatic Hepatocellular Carcinoma, HCC, Combinations of Drugs; Dependence Trial in Tainan, Taipei (GT90001 and Nivolumab)

Active, not recruiting
  • Metastatic Hepatocellular Carcinoma
  • +2 more
  • GT90001 and Nivolumab
  • Tainan, Taiwan
  • +2 more
Jul 8, 2021

Metastatic Hepatocellular Carcinoma, Hepatocellular Carcinoma Trial run by the NCI (vancomycin)

Withdrawn
  • Metastatic Hepatocellular Carcinoma
  • Hepatocellular Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 13, 2020

Metastatic Hepatocellular Carcinoma, Advanced Liver Cancer Trial in Philadelphia (Ascorbic Acid + Sorafenib, Sorafenib)

Completed
Has Results
  • Metastatic Hepatocellular Carcinoma
  • Advanced Liver Cancer
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jul 23, 2018

Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial in Hong Kong (Sorafenib with Capecitabine and

Unknown status
  • Advanced Hepatocellular Carcinoma
  • Metastatic Hepatocellular Carcinoma
  • Sorafenib with Capecitabine and Oxaliplatin
  • Hong Kong, China
    Queen Mary Hospital
Sep 12, 2008